PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025

PETACH TIKVA, Israel, April 29, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its first quarter 2025 financial results and operational highlights before the